FDA警告沃尔玛等售卖涉肉毒杆菌中毒风险婴儿配方奶粉
Xin Lang Cai Jing·2025-12-16 09:05

Core Viewpoint - The FDA has issued stern warning letters to major retailers including Walmart and Target for failing to properly recall baby formula linked to a botulism outbreak, with Kroger and Albertsons also criticized for continuing to sell the affected product [2][3][4]. Group 1: FDA Warnings and Retailer Actions - The FDA has confirmed that the baby formula in question is linked to at least 51 suspected or confirmed cases of infant botulism across 19 states as of December 10 [2][4]. - Target has been criticized for inadequate response measures, continuing to promote the affected formula even after the recall was initiated [2][3]. - The FDA emphasized that all four retailers, including Walmart, Target, Kroger, and Albertsons, failed to provide evidence of corrective actions taken after multiple communications [2][3]. Group 2: Impact of the Outbreak - The CDC has described the severity of the outbreak as "unprecedented," marking the first large-scale infant botulism outbreak in the U.S. [3][8]. - Symptoms of infant botulism can include difficulty eating, loss of head control, swallowing and breathing difficulties, and a weak cry, with a potential incubation period of several weeks [9][10]. Group 3: Retailer Responses - Walmart stated it would formally respond to the FDA's warning and has taken steps to limit the sale of the affected product after receiving the recall notice [10]. - As of now, Target, Kroger, and Albertsons have not provided comments regarding the situation [10].

FDA警告沃尔玛等售卖涉肉毒杆菌中毒风险婴儿配方奶粉 - Reportify